PEAK6 LLC purchased a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 17,516 shares of the financial services provider’s stock, valued at approximately $3,250,000.
Other hedge funds also recently modified their holdings of the company. Solstein Capital LLC acquired a new position in shares of Marsh & McLennan Companies in the 4th quarter worth approximately $25,000. SHP Wealth Management acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at $26,000. KERR FINANCIAL PLANNING Corp bought a new position in Marsh & McLennan Companies in the 4th quarter valued at $27,000. Golden State Wealth Management LLC acquired a new position in Marsh & McLennan Companies in the fourth quarter worth $27,000. Finally, Atlas Capital Advisors Inc. bought a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth $28,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
Insider Activity
In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.
Marsh & McLennan Companies Trading Down 0.3%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s revenue was up 7.6% compared to the same quarter last year. Sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of research analysts recently issued reports on MRSH shares. Barclays cut their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Keefe, Bruyette & Woods raised their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. UBS Group dropped their target price on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research note on Tuesday, June 9th. Bank of America decreased their price target on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research note on Tuesday, April 14th. Finally, Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $200.19.
Read Our Latest Report on MRSH
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
